Improved ejection fraction following optimised treatment for heart failure with reduced ejection fraction in a patient with dilated cardiomyopathy and TNNT2 mutation
Sacubitril/valsartan dose escalation in a patient with low blood pressure and a history of orthostatic syncope under controlled remote monitoring of vital signs